Zeniquin Petitions
Details of Zeniquin's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Pet Medicus Laboratories, Inc. | Approved | 27 May, 2009 | The proposed generic new animal drug is a bi-layered, quadrisected tablet available in 25 mg and 200 mg strengths. The reference listed new animal drug is a coated, single scored tablet available in 25 mg, 50 mg, 100 mg, and 200 mg strengths. The proposed generic new animal drug is intended to deliver the same amount of active ingredient per pound of body weight as the reference listed new animal drug |
About Zeniquin
Zeniquin is a drug
owned by ZOETIS INC.
Zeniquin uses
Marbofloxacin as the active
ingredient.
Active Ingredient:
Zeniquin uses
Marbofloxacin as the active ingredient.
Check out other Drugs and Companies using
Marbofloxacin ingredient.